Skip to main content
Top
Published in: PharmacoEconomics 6/2015

01-06-2015 | Review Article

Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?

Authors: James Buchanan, Sarah Wordsworth

Published in: PharmacoEconomics | Issue 6/2015

Login to get access

Abstract

A long-running debate surrounds the equivalence of the welfarist and extra-welfarist approaches to economic evaluation. There is a growing belief that the extra-welfarist approach may not necessarily provide all the information that decisionmakers require in certain contexts, e.g. evaluation of complex interventions. As the number of these interventions being evaluated increases, it is crucial that the most appropriate economic evaluation approach is used to enable decisionmakers to be confident in their adoption decisions. We conducted a literature review to evaluate the potential for the choice of economic evaluation approach to impact on the adoption decisions recommended by economic evaluation studies. We found that for every five studies applying both approaches, one shows limited or no concordance in economic evaluation results: the different approaches suggest conflicting adoption decisions, and there is no pattern to which approach provides the most convincing adoption evidence. Only one study in ten indicates which results will best inform adoption decisions. We conclude that the choice of approach can significantly impact on the adoption decisions recommended by economic evaluation studies, with conflicting results creating confusion over whether or not interventions provide good value for money. Health economists rarely provide sufficient guidance to decisionmakers to alleviate this confusion.
Appendix
Available only for authorised users
Literature
4.
go back to reference Johannesson M. Theory and methods of economic evaluation of health care (Developments in health economics and public policy, vol. 4). Dordrecht: Kluwer Academic; 1996. Johannesson M. Theory and methods of economic evaluation of health care (Developments in health economics and public policy, vol. 4). Dordrecht: Kluwer Academic; 1996.
5.
go back to reference Brazier J, Ratcliffe J, Saloman J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007. Brazier J, Ratcliffe J, Saloman J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
6.
go back to reference Donaldson C, Birch S, Gafni A. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes. Health Econ. 2002;11(1):55–70. doi:10.1002/hec.642.CrossRefPubMed Donaldson C, Birch S, Gafni A. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes. Health Econ. 2002;11(1):55–70. doi:10.​1002/​hec.​642.CrossRefPubMed
7.
go back to reference Blumenschein K, Johannesson M. Economic evaluation in healthcare. A brief history and future directions. Pharmacoeconomics. 1996;10(2):114–22.CrossRefPubMed Blumenschein K, Johannesson M. Economic evaluation in healthcare. A brief history and future directions. Pharmacoeconomics. 1996;10(2):114–22.CrossRefPubMed
9.
go back to reference Evans KW. Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine. Pharmacoeconomics. 1997;12(5):565–77.CrossRefPubMed Evans KW. Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine. Pharmacoeconomics. 1997;12(5):565–77.CrossRefPubMed
11.
go back to reference Williams A. Economics of coronary artery bypass grafting. Br Med J (Clin Res Ed). 1985;291(6491):326–9.CrossRef Williams A. Economics of coronary artery bypass grafting. Br Med J (Clin Res Ed). 1985;291(6491):326–9.CrossRef
13.
go back to reference Brent RJ. Cost-benefit analysis and health care evaluations. Cheltenham: Edward Elgar Publishing Limited; 2003.CrossRef Brent RJ. Cost-benefit analysis and health care evaluations. Cheltenham: Edward Elgar Publishing Limited; 2003.CrossRef
14.
go back to reference Tsuchiya A, Williams A. Welfare economic and economic evaluation. In: Drummond M, McGuire A, editors. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press; 2001. Tsuchiya A, Williams A. Welfare economic and economic evaluation. In: Drummond M, McGuire A, editors. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press; 2001.
16.
go back to reference Brouwer WB, Koopmanschap MA. On the economic foundations of CEA. Ladies and gentlemen, take your positions! J Health Econ. 2000;19(4):439–59.CrossRefPubMed Brouwer WB, Koopmanschap MA. On the economic foundations of CEA. Ladies and gentlemen, take your positions! J Health Econ. 2000;19(4):439–59.CrossRefPubMed
17.
go back to reference Smith R, Lorgelly P, Al-Janabi H, Venkatapuram S, Coast J. The capability approach: an alternative evaluation paradigm for health economics? In: Jones AM, editor. The Elgar Companion to Health Economics. 2nd ed. Cheltenham: Edward Elgar Publishing Limited; 2012. Smith R, Lorgelly P, Al-Janabi H, Venkatapuram S, Coast J. The capability approach: an alternative evaluation paradigm for health economics? In: Jones AM, editor. The Elgar Companion to Health Economics. 2nd ed. Cheltenham: Edward Elgar Publishing Limited; 2012.
20.
go back to reference Baker R, Currie GR, Donaldson C. What needs to be done in contingent valuation: have Smith and Sach missed the boat? Health Econ Policy Law. 2010;5(Pt 1):113–21.CrossRefPubMed Baker R, Currie GR, Donaldson C. What needs to be done in contingent valuation: have Smith and Sach missed the boat? Health Econ Policy Law. 2010;5(Pt 1):113–21.CrossRefPubMed
21.
go back to reference Brent RJ. A simple method for converting a cost-effectiveness analysis to a cost-benefit analysis with an application to state mental health expenditures. Public Financ Rev. 2002;30(2):144–60.CrossRef Brent RJ. A simple method for converting a cost-effectiveness analysis to a cost-benefit analysis with an application to state mental health expenditures. Public Financ Rev. 2002;30(2):144–60.CrossRef
22.
go back to reference Conrad DA, Deyo RA. Economic decision analysis in the diagnosis and treatment of low back pain. A methodologic primer. Spine. 1994;19(18 Suppl):2101S–6S.CrossRefPubMed Conrad DA, Deyo RA. Economic decision analysis in the diagnosis and treatment of low back pain. A methodologic primer. Spine. 1994;19(18 Suppl):2101S–6S.CrossRefPubMed
24.
go back to reference Phelps CE, Mushlin AI. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int J Technol Assess Health Care. 1991;7(1):12–21.CrossRefPubMed Phelps CE, Mushlin AI. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int J Technol Assess Health Care. 1991;7(1):12–21.CrossRefPubMed
26.
go back to reference Dolan P, Edlin R. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? J Health Econ. 2002;21(5):827–43.CrossRefPubMed Dolan P, Edlin R. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? J Health Econ. 2002;21(5):827–43.CrossRefPubMed
28.
go back to reference Olsen JA, Donaldson C. Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programmes. Soc Sci Med. 1998;46(1):1–12.CrossRefPubMed Olsen JA, Donaldson C. Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programmes. Soc Sci Med. 1998;46(1):1–12.CrossRefPubMed
29.
30.
go back to reference Medical Research Council. Developing and evaluating complex interventions: new guidance. London: Medical Research Council; 2008. Medical Research Council. Developing and evaluating complex interventions: new guidance. London: Medical Research Council; 2008.
31.
go back to reference Hardeman W, Sutton S, Griffin S, Johnston M, White A, Wareham NJ, et al. A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. Health Educ Res. 2005;20(6):676–87. doi:10.1093/her/cyh022.CrossRefPubMed Hardeman W, Sutton S, Griffin S, Johnston M, White A, Wareham NJ, et al. A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. Health Educ Res. 2005;20(6):676–87. doi:10.​1093/​her/​cyh022.CrossRefPubMed
32.
go back to reference Garau M, Towse A, Garrison L, Housman L, Ossa D. Can and should value based pricing be applied to molecular diagnostics? OHE research paper 12/03. London: Office of Health Economics; 2013. Garau M, Towse A, Garrison L, Housman L, Ossa D. Can and should value based pricing be applied to molecular diagnostics? OHE research paper 12/03. London: Office of Health Economics; 2013.
33.
go back to reference The Academy of Medical Sciences. Realising the potential of stratified medicine. London: The Academy of Medical Sciences; 2013. The Academy of Medical Sciences. Realising the potential of stratified medicine. London: The Academy of Medical Sciences; 2013.
34.
go back to reference National Institute for Health and Clinical Excellence. Methods for the development of NICE public health guidance (third edition). London: NICE; 2012. National Institute for Health and Clinical Excellence. Methods for the development of NICE public health guidance (third edition). London: NICE; 2012.
35.
36.
go back to reference Abdul Pari AA, Simon J, Wolstenholme J, Geddes JR, Goodwin GM. Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disord. 2014;16(6):557–82. doi:10.1111/bdi.12213.CrossRefPubMed Abdul Pari AA, Simon J, Wolstenholme J, Geddes JR, Goodwin GM. Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disord. 2014;16(6):557–82. doi:10.​1111/​bdi.​12213.CrossRefPubMed
37.
go back to reference Beale SJ, Bending MW, Trueman P, Naidoo B. Should we invest in environmental interventions to encourage physical activity in England? An economic appraisal. Eur J Public Health. 2012;22(6):869–73. doi:10.1093/eurpub/ckr151.CrossRefPubMed Beale SJ, Bending MW, Trueman P, Naidoo B. Should we invest in environmental interventions to encourage physical activity in England? An economic appraisal. Eur J Public Health. 2012;22(6):869–73. doi:10.​1093/​eurpub/​ckr151.CrossRefPubMed
41.
go back to reference Torrance G, Walker V, Grossman R, Mukherjee J, Vaughan D, La Forge J, et al. Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. Pharmacoeconomics. 1999;16(5 I):499–520. doi:10.2165/00019053-199916050-00007.CrossRefPubMed Torrance G, Walker V, Grossman R, Mukherjee J, Vaughan D, La Forge J, et al. Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. Pharmacoeconomics. 1999;16(5 I):499–520. doi:10.​2165/​00019053-199916050-00007.CrossRefPubMed
42.
go back to reference Driessen M, Bosmans J, Proper K, Anema J, Bongers P, van der Beek A. The economic evaluation of a Participatory Ergonomics programme to prevent low back and neck pain. Work. 2012;41(Suppl 1):2315–20. doi:10.3233/WOR-2012-0458-2315.PubMed Driessen M, Bosmans J, Proper K, Anema J, Bongers P, van der Beek A. The economic evaluation of a Participatory Ergonomics programme to prevent low back and neck pain. Work. 2012;41(Suppl 1):2315–20. doi:10.​3233/​WOR-2012-0458-2315.PubMed
43.
go back to reference Johannesson M, Fagerberg B. A health-economic comparison of diet and drug treatment in obese men with mild hypertension. J Hypertens. 1992;10(9):1063–70.CrossRefPubMed Johannesson M, Fagerberg B. A health-economic comparison of diet and drug treatment in obese men with mild hypertension. J Hypertens. 1992;10(9):1063–70.CrossRefPubMed
44.
go back to reference Liu Y, Mack KA, Diekman ST. Smoke alarm giveaway and installation programs: an economic evaluation. Am J Prev Med. 2012;43(4):385–91.CrossRefPubMed Liu Y, Mack KA, Diekman ST. Smoke alarm giveaway and installation programs: an economic evaluation. Am J Prev Med. 2012;43(4):385–91.CrossRefPubMed
46.
go back to reference Cohen DR, Patel N. The potential to forgo social welfare gains through overreliance on cost effectiveness/cost utility analyses in the evidence base for public health. J Environ Public Health. 2009;2009:107927.CrossRefPubMedCentralPubMed Cohen DR, Patel N. The potential to forgo social welfare gains through overreliance on cost effectiveness/cost utility analyses in the evidence base for public health. J Environ Public Health. 2009;2009:107927.CrossRefPubMedCentralPubMed
47.
go back to reference McIntosh E, Clarke PM, Frew E, Louviere JL, editors. Applied methods of cost-benefit analysis in health care. Oxford: Oxford University Press; 2010. McIntosh E, Clarke PM, Frew E, Louviere JL, editors. Applied methods of cost-benefit analysis in health care. Oxford: Oxford University Press; 2010.
49.
go back to reference National Institute for Health and Care Excellence. Process and methods guides. Guide to the methods of technology appraisal 2013. London: NICE; 2013. National Institute for Health and Care Excellence. Process and methods guides. Guide to the methods of technology appraisal 2013. London: NICE; 2013.
Metadata
Title
Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?
Authors
James Buchanan
Sarah Wordsworth
Publication date
01-06-2015
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 6/2015
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-015-0261-3

Other articles of this Issue 6/2015

PharmacoEconomics 6/2015 Go to the issue